IXICO plc (PYPB.F)
- Previous Close
0.0795 - Open
0.0795 - Bid 0.0765 x --
- Ask 0.0955 x --
- Day's Range
0.0795 - 0.0795 - 52 Week Range
0.0740 - 0.2300 - Volume
2,250 - Avg. Volume
36 - Market Cap (intraday)
4.286M - Beta (5Y Monthly) 0.65
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date May 21, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. In addition, the company focuses in therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, and orphan and rare diseases. Further, the company engages in the data collection and analysis of neurological disorders. Additionally, it offers drug development analytics, imaging operation, post marketing surveillance, and consultancy services; and end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.
ixico.comRecent News: PYPB.F
Performance Overview: PYPB.F
Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PYPB.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PYPB.F
Valuation Measures
Market Cap
4.14M
Enterprise Value
-90.72k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.50
Price/Book (mrq)
0.29
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-17.67%
Return on Assets (ttm)
-6.50%
Return on Equity (ttm)
-9.85%
Revenue (ttm)
6.67M
Net Income Avi to Common (ttm)
-1.18M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
4.03M
Total Debt/Equity (mrq)
3.38%
Levered Free Cash Flow (ttm)
-1.42M
Research Analysis: PYPB.F
Company Insights: PYPB.F
PYPB.F does not have Company Insights